Bloom Energy is Fully Priced: Is a Re-rating Coming?
Bloom Energy has quadrupled in a year by becoming the default power solution for AI hyperscalers, but three blowout quarters later, the stock's next move hinges on whether that success is a launchpad or the ceiling.
At $252.87, Bloom Energy (NYSE:BE) sits at a crossroads. The stock has quadrupled in twelve months on an AI onsite-power thesis that has already delivered, leaving the debate over whether the next leg is earned or already reflected.
Bloom sells solid oxide fuel cell systems that hyperscalers, neoclouds, and colocation operators are deploying to bring gigawatts of AI compute online faster than the grid can support (the same power, cooling, and networking angle we mapped in a free report on seven AI infrastructure suppliers that aren’t chipmakers). CEO KR Sridhar has said “Bloom is now a standard for AI onsite power,” and all major US hyperscalers plus more than a dozen neoclouds, AI labs, and colocation operators have validated the platform.
The re-rating has been extraordinary. Shares are up 360.52% over the past year and 191.02% year to date, versus 18.65% and 12.94% for the S&P 500. Q2 FY26 revenue crossed $1 billion in a single quarter for the first time, marking a fourth consecutive EPS beat and cementing Wall Street’s willingness to pay a growth multiple.
Why Bulls See More Room to Run
Fundamentals are still accelerating faster than the multiple. Q2 revenue of $1.065 billion grew 166% year over year, product revenue jumped 215% to $935 million, and operating income vaulted 737% year-over-year to $240 million. Management raised full-year 2026 guidance a third time to $3.9B-$4.2B in revenue and $2.55-$2.85 in non-GAAP EPS.
Backlog supports the trajectory: roughly $20 billion total, with product backlog near $6 billion. Brookfield expanded its financing framework from $5 billion to $25 billion. The 2026 EPS consensus has climbed from 2.1267 to 2.7062 in 90 days, with 24 upward revisions and zero cuts in the trailing month. On 2027 consensus EPS of 4.9201, the forward multiple compresses meaningfully as growth converts.
Why Bears See a Stock Priced Too High
Trailing P/E sits at 333x, price/sales at 24, and EV/EBITDA at 199x. The 2027 EPS range of 2.9548 to 7.0100 across 28 analysts signals genuine disagreement on backlog conversion. Insiders have been consistent sellers: Director Jeffrey Immelt disposed of 30,000 shares at $238.91, Director John Chambers sold 15,000 at $250 and another 15,000 at $205.58, and Chief Commercial Officer Aman Joshi unloaded 8,343 shares at $300.37.
Overhangs are real. A securities class action carries a September 28, 2026 lead-plaintiff deadline. Stock-based comp is running near $52 million per quarter, GAAP FY2025 was still a net loss of $88.4 million, and the story remains tethered to IRA and One Big Beautiful Bill Act tax credits, Brookfield-linked revenue, and continued hyperscaler capex intensity.
Why the Setup Rewards Patience
Execution is undeniable, but the price now embeds most of what management has promised through 2027. Beta of 3.811 means any wobble in AI capex sentiment gets amplified. S&P 500 inclusion, announced Sept. 4, adds a one-time index bid, though that is a one-time technical event.
What tips the verdict is straightforward. Another guidance raise on the Q3 report, visible backlog conversion, and clarity on the litigation would open a path back to Buy. A capex airpocket at hyperscalers, a margin miss, or an adverse court development would open the door to Sell. Right now, neither signal is in hand.
What the Numbers Actually Say
Bloom currently trades at $252.87, up 7.35% on its most recent session and 19.97% over the past week. The 29 covering analysts carry an average price target of $275.08, implying upside to the consensus target. Ratings break down as follows:
- 5 Strong Buy
- 10 Buy
- 12 Hold
- 1 Sell
- 1 Strong Sell
Analyst targets are one data point, not a guarantee, and this target sits well below the 52-week high of $351.28. The valuation debate lives here: forward P/E of 49x, price/book of 43x, and EV/revenue of 22x. Against the S&P 500’s 18.65% one-year return, Bloom’s 360.52% gain shows how much AI-power optionality is already in the price.
Why Waiting Beats Chasing at $252.87
At $252.87, Bloom Energy sits in a wait-and-see zone. Here is why.
The bull case has largely been vindicated by three consecutive blowout quarters, which is precisely why the risk/reward has shifted. Buying here requires believing 2027 EPS lands in the upper half of the 2.9548 to 7.0100 range and that the forward multiple compresses only modestly. That outcome is plausible but demands flawless execution against a live litigation deadline, active insider selling, and a highly cyclical AI capex backdrop.
Selling is equally difficult. Guidance keeps rising. Cash flow from operations swung from -$213 million a year ago to $226 million last quarter. The company closed Q2 with $2.7 billion of cash and a $25B Brookfield shelf behind it. Fundamentally, the business is intact.
The Q3 earnings report, the September 28 litigation deadline, and the pace of backlog conversion into 2027 revenue will decide whether $252.87 was a launchpad or a ceiling. At today’s price, Bloom Energy deserves respect on the business, but patience on the position.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
